DMSO is the standard solvent for preparing stock solutions of compounds for drug discovery. The assay concentration of DMSO is normally 0.1% to 5% (v/v) or 14 to 715 mM. Thus, DMSO is often one of the principal additives in assay buffers. This standardization of stock solutions does not eliminate possible pitfalls associated with the effects of the DMSO-containing solutions on individual proteins. In this article, the authors want to emphasize the importance of detailed studies of these effects in the early stages of drug discovery. Two protein systems, the extracellular soluble domain of the human growth hormone receptor (hGHbp) and the phosphatase domain of PFKFB1 (BPase), were used for the study on effects of DMSO on protein stability, protein aggregation, and binding of drug compounds. The study revealed significant differences in the proteins' behavior in the presence and absence of low amounts of DMSO. The addition of DMSO resulted in destabilization of the proteins investigated and also changed the apparent binding property of 1 protein. The authors have also shown that low DMSO concentrations influence the ionization process in electrospray ionization mass spectrometry (ESI-MS). (Journal of Biomolecular Screening 2006:131-137) 
INTRODUCTION P HARMACEUTICAL COMPANIES HAVE MADE large investments
in automated high-throughput screening (HTS) facilities. It is the standard tool for obtaining chemical starting points from unique chemical compound libraries. The success of an HTS campaign is dependent on the content and quality of the chemical library, the choice of screening assay, and the liquid-handling procedures. Because of the large number of compounds tested in an HTS, the process needs to be rationalized and automated. For this reason, an industry standard has been developed for the liquid handling of compounds. DMSO has been chosen as the standard solvent for the stock solutions of the compounds due to favorable properties in terms of dissolving ability, low chemical reactivity, and low vapor pressure. Commonly, stock solutions of compounds in DMSO are prepared at 2 standard concentrations: 2 mM or 10 mM. In an HTS campaign, each compound is normally tested at 2 different concentrations, 1 µM and 10 µM, followed by a concentration response screen of the initial hits. The drug discovery process proceeds with the hit compounds from the dose-response screens using an array of different biological and biophysical methods. In the dose-response screens, the compound concentration ranges may include concentrations approaching 100 µM. Normally, the post-HTS biophysical methods require higher concentrations of proteins and compounds compared to the HTS phase. Thus, the concentration of DMSO in the assays as well as during biophysical characterization can vary between 0.1% (v/v) and 5% (v/v) depending on the compound concentration of the stock solution used, assay type, and required concentration range of the compounds.
There are a number of articles published on issues about the storage of compounds in DMSO stock solutions. 1, 2 Cheng et al. 1 discuss the significance of water absorption, repeated freeze/thaw cycles, and container materials and how these conditions could cause compound instability in DMSO. 1, 2 However, the possible effects of DMSO on proteins during screening have received little attention in the literature. Previous studies on the effects of DMSO on proteins have mostly been performed at very high DMSO concentrations (10%-70% DMSO). These studies show that DMSO can influence the properties of proteins in various ways. DMSO can act as a stabilizer 3, 4 as well as a denaturant. [5] [6] [7] [8] DMSO can act as an inhibitor [9] [10] [11] as well as an activator. 12 There are only a few reports on how low concentrations of DMSO affect proteins. One recent paper by Yang et al. 13 shows a distinct change in the unfolding pathway of dimeric bacterial NAD + synthetase upon adding DMSO to a concentration of 2.5%.
In this work, we have studied how DMSO at normal assay concentrations may change protein properties, which in turn can influ-ence the outcome of assay data. The effect of lower amounts of DMSO (0.1%-3%, v/v) on 2 protein systems has been investigated: the extracellular soluble domain of human growth hormone receptor (hGHbp) and the phosphatase domain of PFKFB1 (BPase). The amount of DMSO in our studies is in close proximity to the amount of DMSO normally used in assay screens. Several biophysical methods were used to study both technique-related and protein-related issues of assay buffers containing DMSO: electrospray ionization mass spectrometry (ESI-MS), differential scanning calorimetry (DSC), analytical ultracentrifugation (AUC), circular dichroism (CD), and dynamic light scattering (DLS). The studies involved characterization of the proteins with and without DMSO as well as protein-ligand characterizations.
EXPERIMENTAL SECTION

Materials
All reagents used were of highest purity available. Ammonium acetate, DMSO, dimethyl formamide (DMF), and 2-propanol were from Merck (Darmstadt, Germany). The 2 proteins used in this study, hGHbp and BPase, were produced from overexpressed plasmids in Escherichia coli and purified in-house. The purity was higher than 95% for both hGHbp and BPase, according to SDS-PAGE. The compounds used were synthesized in-house.
Mass spectrometry
Prior to mass spectrometry (MS) analysis, the 2 proteins were dialyzed offline against either 20 mM ammonium acetate, pH 8 (BPase), or 10 mM ammonium acetate, pH 7 (hGHbp), by means of a Slide-a-lyzer (Pierce, Rockford, IL), MWCO 10000. All solutions were filtered through a 0.45-µm nylon filter to remove particles. The sample handling was carried out at 15°C. The samples were introduced into the electrospray ion source by means of a CapLC pump system (Waters, Milford, MA). The mobile phase used was 10 mM ammonium acetate, pH 7, and the sample flow rate was 5 µL/min. The ESI mass spectra were recorded on a quadrupole time-of-flight (Q-TOF) Ultima API instrument (Micromass, Manchester, UK), operating in positive ion mode. A capillary voltage of 3000 V was applied along with a cone voltage of 100 V. The source block temperature and the desolvation temperature were set to 45°C and 60°C, respectively. The desolvation gas flow was 200 L/h, and the cone gas flow was 50 L/h. To preserve the noncovalent interactions in the gas phase, the source backing pump was throttled to give a reading of 2 mbar on the backing line Pirani gauge. Ar was introduced into the collision cell to give a reading on the analyzer penning pressure gauge of 1.8e-5 mbar. Data were acquired by scanning over the m/z range 1000-5000, with data accumulation of 2 s per spectrum and an interscan time delay of 0.1 s. In each experiment, mass spectra were averaged over 80 scans.
To quantify the amount of degradation product at different incubation times, the peak heights of the transformed peaks corresponding to the degradation product at 26.6 kDa and the intact BPase at 27.7 kDa were measured. The peak height ratios obtained were plotted against incubation time for the 2 samples with and without 0.5% DMSO, respectively.
Differential scanning calorimetry (DSC)
Differential scanning calorimetry was performed on VP-DSC (Microcal Inc., Northampton, MA). The scanning rate was set to 60°C/h in all experiments. The data were analyzed with Origin ™ software (Microcal Software Inc., Northampton, MA) supplied with the instrument.
Analytical ultracentrifuge (AUC)
Analytical ultracentrifugation was performed on a Beckman XLI analytical ultracentrifuge (Palo Alto, CA). Data were collected with an interference detector. Sedimentation velocity experiments were carried out at 15°C at the rotor speed of 50 krpm. The 2-chamber centerpiece was loaded with a 0.44-mg/mL BPase solution and a buffer solution as a reference. Data were analyzed with the program SEDFIT. 14
Circular dichroism (CD) spectroscopy
CD measurements were conducted on a Jasco J-720 spectropolarimeter (Jasco Corp., Tokyo, Japan). The temperature in the sample holder was controlled by a peltier element (PTC-348 WI). Data collection and evaluation were carried out by the software supplied with the instrument. The blank spectra of the corresponding buffers were subtracted from the CD spectra of the BPase solutions.
Dynamic light scattering (DLS)
Dynamic light scattering studies were carried out on a DynaPro MS800 instrument (Wyatt Technology Corp., Santa Barbara, CA) equipped with a 248-channel Multi-Tau USB correlator and a temperature control unit. Control of the instrument, data collection, and evaluation were carried out by DYNAMICS ™ software. Protein solutions were loaded into a 12-µL quartz cuvette, and the measurements were carried out at 15°C and 25°C. The data acquisition time was set to 10 s. The result of the measurement represented the average of 10 acquisitions. The DLS studies were performed on BPase. The protein solutions were incubated on ice for 1 h prior to the measurements to obtain consistency with the protein preparations for CD and DSC analysis.
RESULTS AND DISCUSSION
Protein characterization
Influence of DMSO on protein folding. The effect of DMSO on the stability of BPase was studied by nondenaturing ESI-MS. The usefulness of this technique to distinguish between folded and unfolded protein is well known. 15 The multiply charged ions observed in the mass spectrum are mainly produced as a result of protonation of basic residues on the protein. The conformation of the protein determines the availability of basic sites. Normally, unfolding of a protein leads to an increased number of basic sites available for protonation, which in the mass spectrum can be observed as a shift in the charge state distribution toward higher charge states (lower m/z). In addition, the charge distribution for folded proteins demonstrates just 2 or 3 intense peaks, whereas unfolded proteins have a broad bell-shaped distribution of charges. 16 The BPase (0.7 µM in 20-mM ammonium acetate, pH 8) was analyzed in samples containing 0%, 0.5%, and 3% DMSO, respectively ( Fig. 1) . At DMSO concentrations of 0.5%, 2 changes of the charge state envelope were observed (Fig. 1B) . First, a broadening of the charge state distribution occurred, so that 4 charge states instead of 3 were observed. This indicates that the protein has changed its conformation to a partially unfolded state. The 2nd, more surprising, observation was that the charge state envelope of the protein shifted toward lower charge states (higher m/z) compared to the DMSO-free sample, which would indicate a more compact protein structure at 0.5% DMSO. This is contradictory to our other biophysical data that showed a reduced stability of the protein at 0.5% DMSO. A plausible explanation for the observed m/z shift to lower charge states is that the shift was induced by DMSO in the electrospray ionization process rather than reflecting a structural change of the protein in solution. There are similar observations previously reported of an m/z shift toward lower charge states in ESI-MS of native proteins 17, 18 when adding DMSO, but to our knowledge, the effect has not been explained. The pH in the solutions was found to be unchanged (pH 8) after the addition of DMSO. At 3% DMSO concentration, the charge state envelope started to shift toward higher charge states, indicating unfolding. In Figure 1C , 3 different clusters can be observed: 1) the ions with charge states 10+ to 8+ correspond to a protein in the same folding state as at 0.5% DMSO concentration, 2) the ions labeled 13+ to 11+ correspond to a distinctly more unfolded protein, and 3) the cluster with ions at the highest charge states 25+ to 21+ corresponds to fully denatured protein (the increased number of charge states observed for denatured proteins is a result of the increased number of basic sites available for protonation). Thus, at a concentration of 3% DMSO, the amount of active, native enzyme was decreased significantly.
At 0.5% DMSO concentration, the protein envelope was shifted toward lower charge states compared to the DMSO-free sample (Fig. 1B) . Commonly, this change would be interpreted as a structural change to a more compact protein. However, that would be contradictory to our other biophysical data showing a reduced stability of the protein at 0.5% DMSO. To find an explanation to the unexpected m/z shift, we compared the ESI charge state distribution with that of another native protein (hGHbp) in the absence and presence of DMSO. In addition, the protein was studied in the absence and presence of 0.5% of 3 other solvents, respectively. The cosolvents were added to 3-µM protein solutions in 10 mM ammonium acetate, pH 7 (Fig. 2) . The pH was measured after the addition of each cosolvent and found to be unchanged. The cosolvents were chosen so that they had either a lower boiling point than water, acetonitrile (bp 81°C), and 2-propanol (bp 82°C) or a higher boiling point than water, DMSO (bp 189°C), and DMF (bp 155°C). Neither acetonitrile nor 2-propanol changed the charge state distribution of the protein. However, the high boiling point cosolvents resulted in similar m/z shifts of the charge state distribution. The effect on the protein ion signal intensity in the mass spectra after addition of the solvents was also investigated ( Table 1) . Acetonitrile and 2-propanol did not give any significant effects on the signal intensity, whereas both DMSO and DMF caused decreased signal intensity, 29% and 41% of the original signal level, respectively. These findings indicate a significant reduction in gas phase ion formation in the electrospray ionization process due to effects caused by the addition of low vapor pressure cosolvents. As explained by Peschke et al., 19 macromolecular ions are produced from very small droplets. The radius of the droplets decreases because of solvent evaporation until it reaches the size of the protein. Due to the low vapor pressure of DMSO and DMF, the concentration of these cosolvents will be enriched in the electrospray droplet during the solvent evaporation. This influences the ability of the protein to behave as a proton acceptor, resulting in a loss of protein ion current and an m/z shift to lower charge states. During the vaporization process, the solvent composition and pH of the small droplets will change. For a 90% DMSOwater mixture, the pH is 9.6. The change in pH will decrease the basic sites available for protonation of the protein, resulting in an m/z shift to lower charge states. Higher pH is a documented reason for changes in the charge state envelope to lower charge states. 15 Thus, when using ESI-MS for analyzing proteins in DMSOcontaining solvents, an awareness of these effects is important for a correct interpretation of the MS results.
DMSO-Related Effects in Protein Characterization
Influence of DMSO on protein stability. The thermal stability of BPase was studied by DSC in the absence of DMSO and at 0.5% and 1% DMSO. The total apparent enthalpy of unfolding of BPase is dependent on the DMSO content. The enthalpy of unfolding is 60% lower for the protein in 0.5% DMSO than in DMSO free solvent. In the presence of DMSO, the temperature gradient of the heat capacity is higher than in DMSO free solvent. This suggests an enhanced aggregation of the protein in the presence of DMSO (Fig. 3) . Concomitantly, the extent of the protein aggregation at higher temperatures was significantly increased. At 1% DMSO, protein unfolding and aggregation were taking place already at room temperature, and the processes taking place during the temperature scan are difficult to define and thus to describe thermodynamically.
The results from the calorimetric unfolding experiments suggest that the protein is affected structurally by the presence of DMSO.
The secondary structure of BPase, as well as its dependence on a low concentration of DMSO, was studied by CD. The low DMSO concentrations (0%-0.4%) were chosen to avoid the artifacts caused by a significant contribution from intrinsic UV absorption by DMSO at higher concentrations. Far-UV CD spectra (not shown) demonstrated that DMSO apparently induced significant changes in the time-averaged secondary structure. The alpha helical content of the protein, as measured at 222 nm, gradually decreased with the increase of the DMSO concentration (Fig. 4) .
DMSO changes not only the physiochemical properties of BPase but also its chemical stability. From ESI-MS measurements, we could conclude that DMSO destabilizes BPase by promoting degradation of the protein (Fig. 5) . Two samples containing 3 µM enzyme in 20 mM ammonium acetate, pH 8, were compared in the presence and absence of 0.5% DMSO. The 2 samples were analyzed 0, 1, 3, 6, and 20 h after preparation. The samples were stored at +15°C during the study. After 1 h, degradation of the enzyme was observed in both samples, and the degradation process had progressed twice as much in the presence of DMSO. The degradation product is the same in both samples and corresponds to a loss of 10 N-terminal amino acids with a cleavage site between glycine and methionine. As shown in Figure 5 , the rate of degradation is highly dependent on the presence of 0.5% DMSO. Influence of DMSO on protein aggregation. The DSC data indicate that the degree of aggregation may be dependent on DMSO content. To further investigate this indication, we performed a study of the aggregation state of the same enzyme in detail using AUC and DLS. AUC results (Fig. 6) show that in the DMSO-free buffer, the protein was predominantly in a monomeric state (about 75 wt.%). The next populated fraction was dimers (10 wt.%). The content of the large aggregates (5 < N < 30) was around 15 wt.%. In the presence of 0.5% DMSO after 1 h incubation on ice, the size distribution shifted to the higher aggregation numbers. The content of the monomers decreased by 15 wt.%, the fraction of dimers remained essentially unchanged, and the content of the higher aggregates increased by a factor of 2. Notably, the AUC data analysis resulted in different friction ratios for the protein monomers in the absence and in the presence of DMSO, 1.34 and 1.27, respectively. This difference may reflect a conformational change of the protein.
The same trend was apparent from DLS measurements carried out on the free protein solution and the protein solution in the presence of 0.5% DMSO ( Table 2) . The presence of DMSO resulted in complete disappearance of the protein monomer peak at 2.6 nm. At the same time, the content of the large-size aggregates clearly increased. An attempt to measure the size distribution in the protein solution at 1% DMSO failed due to the saturation of the DLS detector caused by very high scattering intensity, which was increasing with time. One may hypothesize that the increase in DMSO content not only induces a higher degree of aggregation but also accelerates the rate of aggregation. 
Protein-ligand binding characterization
Influence of DMSO on protein-ligand interaction. We have earlier described the use of nondenaturing ESI-MS as a method to determine affinities between proteins and low molecular mass molecules. 18 As a model system for the method, we used the interactions between hGHbp and low-molecular mass compounds. During the development of the method, we found that the affinities of the lowmolecular mass compounds are dependent on the DMSO content. To investigate the impact of DMSO on ligand binding, an ESI-MS experiment was performed where the amounts of protein and a reference ligand were constant, and the amount of DMSO was increased in each sample. As a control, 3 other cosolvents were investigated in a similar way as DMSO: DMF, acetonitrile, and 2propanol. The normalized ESI-MS signal ratios between the protein-ligand complex and the free protein from the deconvoluted mass spectra were plotted against the amount of cosolvent added (Fig. 7) . No apparent change of the protein-ligand complex affinity was observed in the samples containing 0% to 1% of acetonitrile and 2-propanol. In the sample containing 0% to 1% DMF, a decrease could be observed at the highest DMF concentration, but we did not see a distinct trend of weakening binding affinity with higher DMF concentration. However, in the samples containing 0% to 1% DMSO, the apparent ability for the ligand to bind to the protein was significantly weakened with increasing amounts of DMSO. The decrease in apparent binding affinity between the protein and the ligand could not be explained by progressing protein destabilization; the charge state envelope of the protein at the lowest (0.1%) as well as the highest (1%) DMSO concentration had the same appearance (hGHbp shows higher stability in the presence of DMSO than BPase). A plausible explanation is that DMSO acts as a competing ligand. Similar effects have been reported on alcohol dehydrogenase. 20, 21 
CONCLUSION
Standard procedures for the liquid handling of compounds in HTS are important as the process needs to be automated. The favorable properties of DMSO as a standard stock solution for chemical libraries are well documented. Although DMSO is present at relatively low concentrations in screening buffers, it may be one of the most dominant components in the buffer. The factor between the percentage of DMSO and the concentration of DMSO (in mM) is 143; for example, a solution of 1% DMSO (v/v) corresponds to 143 mM DMSO. It appears that the ability of DMSO to dissolve organic compounds in many cases is limited and could be well below the expected concentration of 10 mM (in-house unpublished data). This, apart from the reported problem of stability on storage, could result in a poor control over the final concentrations of the compounds in HTS buffers and also in underestimated or overestimated IC 50 values. This calls for caution and awareness and stresses the necessity of analytical tools for ensuring chemical and physiochemical integrity of the compounds used in the screening activities. The same caution and awareness need to be exercised with the proteins used in the drug discovery process. In the present study, we have shown that DMSO at relatively low concentrations can change the properties of proteins in solution, leading to protein denaturation, aggregation, or degradation. DMSO can also change the apparent binding properties of the proteins. This can be due to physiochemical properties of the compound or the protein in DMSO, DMSO interference on the analyzing method, or combinations of the 3. This means that the enzymatic activity of an enzyme may not be affected by low DMSO concentrations, but binding properties of the same enzyme to compounds may be affected due to the above given reasons.
We want to emphasize the importance of scrutinizing the most appropriate solvents for individual proteins at early stages. Unforeseen future assay problems may be avoided if an early knowledge on how proteins behave in DMSO-containing solvents is established.
One should also be aware of the ability of DMSO to interfere with instrumental response. Here we have shown that low DMSO concentrations influence the ionization process in ESI-MS, resulting in a loss of the protein ion signal intensity as well as a decrease in the basic sites available for protonation on the protein.
The use of DMSO as a standard cosolvent is based on rational criteria. However, the different effects caused by DMSO that have been described here are not unique for these protein systems. We have experienced combinations of the different types of DMSOinduced phenomena presented here on many other protein systems. The observed effects could not be directly related to particular classes of proteins because DMSO effects can vary significantly from construct to construct of the same protein. , acetonitrile, and 2-propanol) in percentages (v/v) is plotted against the normalized ratio between the peak heights corresponding to the proteinligand complex (ML) and the free protein peak (M) in the deconvoluted electrospray ionization mass spectrometry (ESI-MS) spectra.
characterization of compounds and proteins in low-DMSO content assay buffers is essential for high-quality drug discovery.
